December 2007 Volume 3, Issue 12

Volume 3, Issue 12 | December 2007

December 2007

In this Issue

Informatics

Drug Discovery News Placeholder Image

Free for all (students)

Accelrys makes SciTegic Pipeline Pilot Student Edition free to academic researchers
Drug Discovery News Placeholder Image

Schizophrenia data deal

Genizon Biosciences and NDEI to share samples, technology

Automation & Instrumentation

Drug Discovery News Placeholder Image

One molecule at a time

Team-up of Agilent and BioNanomatrix focuses on nanoscale whole-genome imaging and analysis
Drug Discovery News Placeholder Image

WaferGen’s alpha dog

Pitt Med School tapped as alpha test site for WaferGen’s real-time PCR system
Drug Discovery News Placeholder Image

Xceed launches Strategic Collaborator program

Xceed has already committed to several other institutions under its Strategic Collaborator program

Genomics & Proteomics

Drug Discovery News Placeholder Image

Band-aid for the brain?

Alzheimer’s drugs target symptoms not disease
Drug Discovery News Placeholder Image

On your mark, get set...

NextGen appoints new CEO and expands services into protein biomarker monitoring
Drug Discovery News Placeholder Image

RXi and Invitrogen: All quiet on the RNAi front

RXi Pharmaceutical and Invitrogen announced they have entered into an agreement for RXi to license on an exclusive basis second-generation RNAi technology from Invitrogen for designated target genes in all human therapeutic categories.

Research & Development

Drug Discovery News Placeholder Image

Putting on a new spin

Amgen spins out Relypsa from newly acquired Ilypsa
Drug Discovery News Placeholder Image

Antisense approach to scars

Isis and Excaliard look to topical antisense drugs to treat scars and other fibrotic conditions
Drug Discovery News Placeholder Image

SRI vs. HIV

SRI in new contract with NIAID for preclinical services
Drug Discovery News Placeholder Image

Rosetta and NYU expand microRNA collaboration

Israel-Rosetta Genomics Ltd. and the New York University School of Medicine have expanded their collaboration to include congenital heart disease.
Drug Discovery News Placeholder Image

Gene Logic discovers new use for Pfizer drug

Gene Logic Inc. recently announced a collaboration milestone, triggered by the filing of a patent application for a new use of an existing Pfizer drug candidate to treat solid tumors

Global News

Drug Discovery News Placeholder Image

All that glitters

Nanoengineers mine tiny diamonds for drug delivery
Drug Discovery News Placeholder Image

GPC begins restructuring

Staff reductions of approximately 44 percent are in store for GPC Biotech AG after the recent announcement of a corporate restructuring plan
Drug Discovery News Placeholder Image

Allies against Alzheimer’s

Biogen Idec and Neurimmune to work on antibody-based treatment for AD
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue